Stay updated on Pembrolizumab & Romidepsin Combo Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Romidepsin Combo Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision notices (v3.4.2 and v3.4.1) are minor platform updates and do not alter study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T06:25:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and the NIH Clinical Center status with guidance to check updates. Updated the page revision to v3.4.1 and removed the previous v3.4.0 revision.
    Difference
    0.4%
    Check dated 2026-02-04T05:16:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria and Last Update Posted) along with a new page revision tag (Revision: v3.4.0). Minor capitalization and wording updates (e.g., No FEAR Act Data) were applied, replacing the previous text and version (v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-28T03:25:00.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page record shows January 2026 metadata additions, including Last Update Posted (Estimated) and Revision: v3.3.4, with corresponding July 2025 entries (Revision: v3.3.3) removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-14T03:20:44.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section with a Texas site (M.D. Anderson Cancer Center) and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the combined 'Texas Locations' label (v3.3.2).
    Difference
    0.2%
    Check dated 2025-12-23T21:28:57.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Romidepsin Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.